As part of their quality system, national competent authorities and the Agency should establish contact points to facilitate interaction between national competent authorities, the Agency, the Commission, marketing authorisation holders and persons reporting information on the risks of medicinal products, as referred to in the second subparagraph of Article 101(1) of Directive 2001/83/EC.
Recital 7, Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance o…
In forcesince 31 Dec 2020